CD8A and neoplasm: These include mechanisms of resistance involving T cell immune checkpoint pathways, intratumoral heterogeneity, inadequate production and function of tumor-specific CD8+ T cells, and scarcity of suitable neoantigens with impaired processing and presentation [13].